The Assessment of Bone Mineral Density (BMD) and Fracture Risk after 3 Years of Adjuvant Zoledronic Acid in Postmenopausal (ER+) Early Breast Cancer
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 27
(8)
◽
pp. 1627-1634
◽
2014 ◽
Vol 25
(4)
◽
pp. 1369-1378
◽
Keyword(s):
Keyword(s):
Keyword(s):